Skip to content

Investigation of the Effect of Abzan on distal diabetic neuropathy.

Investigation of the Effect of Abzan(Foot bath) on lower extremity pain in Patients with distal diabetic neuropathy.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180912041016N1
Enrollment
60
Registered
2018-10-13
Start date
2018-10-23
Completion date
Unknown
Last updated
2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Distal diabetic neuropathy.. Other specified diabetes mellitus with diabetic polyneuropathy

Interventions

Intervention 1: The first intervention group participates in the sitting chair and places the legs for 15 minutes each night in a container containing 6 liters of warm water (water temperature between

Sponsors

Ghoum University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. HbA1C<10 ? BS<200. 2. Age between 30 and 70 years 3. Over 3 months after symptoms of diabetic polyneuropathy 4. Is willing to participate in the study

Exclusion criteria

Exclusion criteria: There is a history of other diagnosis of pain and other signs of lower extremity neuropathy (including the lumbar disc). Complications of kidney, cardiovascular and unstable brain, and other diseases (malignancy, rheumatologic diseases, thyroid diseases and other hormonal diseases, other diseases). Patients who received systemic corticosterone within last month. The presence of injured lesions in the legs Pregnancy and breastfeeding Patients who take other medicines for weight loss, thyroid disease, or other hormonal disorders. There is a history of using techniques such as massage, cupping and ... within a month before the study. Patients with a blood pressure lower than 100 mmHg or a low blood pressure state.

Design outcomes

Primary

MeasureTime frame
Sensory perception of diabetic distal neuropathy. Timepoint: At the beginning of the study (before the intervention) and on days 15 and 30 after the intervention. Method of measurement: DN4 pain questionnaire.

Secondary

MeasureTime frame
The average blood pressure. Timepoint: At the beginning of the study (before the intervention) and the end (30 days later). Method of measurement: Richter mercury pressure indicator.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Reza Vakilinia

Ghoum University of Medical Sciences

vakilireza45@gmail.com+98 25 3292 7921

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026